[ Price : $8.95]
FDA accepts for review a Vivus Inc. NDA for EvaMist, indicated for treating vasomotor symptoms associated with menopause.[ Price : $8.95]
In its latest batch of Warning Letters, FDA cites Dupaco, Health Dimensions, Radiometer Medical, Robert Ritch, Skytron, and Spoona...[ Price : $8.95]
Federal Register Proposed rule: FDA proposes to add to its labeling requirements a definition and the option of alternative labeli...[ Price : $8.95]
Federal Register Notice: FDA changes the time for the 12/15 meeting of the Medical Devices Dispute Resolution Panel.[ Price : $8.95]
Federal Register Final rule: FDA approves an Elanco Animal Health sNADA for an alternate feed regimen for tylosin phosphate in swi...[ Price : $8.95]
Neopharm Inc. says a pivotal Phase 3 trial involving an experimental cancer drug failed to meet its efficacy endpoint.[ Price : $8.95]
Researchers say doctors respond better to general requests for antidepressant medications rather than to requests for specific dru...[ Price : $8.95]
New Zealands government backs away from restricting drug DTC ads.